Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
SNM Organization

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 16 February 2001:
Vol. 291. no. 5507, p. 1161
DOI: 10.1126/science.291.5507.1161c

Editors' Choice: Highlights of the recent literature

How do viruses evade detection and clearance? Strategies used range from inhibiting antigen processing and presentation to establishing latent or dormant nonreplicative infection. The herpes virus family is particularly adept at both. Latent infection established by Epstein-Barr virus (EBV) in B cells is marked by the constitutive expression of the latent membrane protein 2A (LMP2A). Cells expressing LMP2A exhibit impaired B cell receptor (BCR) activation. Dykstra et al. show that LMP2A acts to prevent the BCR-initiated cascade of phosphorylation by blocking BCR translocation into lipid rafts (plasma membrane microdomains rich in cholesterol and sphingolipid); this also serves to block antigen complex processing because the requisite BCR internalization from rafts is diminished. Thus, LMP2A interferes with the immune clearance of virus by dampening B cell activation and inhibiting the T cell-mediated recognition of virus-infected B cells. -- JN

Immunity 14, 57 (2001).





ADVERTISEMENT
Click Me!

ADVERTISEMENT

To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)